Industry professionals discussed the development of the biotechnology ecosystem in Portugal and Spain during an episode of Denatured, released on June 11. The discussion focused on how both countries are working to strengthen their positions within the European life sciences investment landscape.
The episode featured Hannah Franklin, associate at Biovance Capital, and Pablo Gabriel Cironi Lopez, director of life science investment at Caixa Capital Risc. They addressed Portugal’s initiatives to transform strong scientific research into startup companies, as well as Spain’s increasing pool of capital and talent.
Jennifer C. Smith-Parker, director of insights at BioSpace, hosted the conversation. The guests explored what it will take for the Iberian region to compete globally in biotechnology.
According to Franklin and Cironi Lopez, continued investment and support for innovation will be necessary for both countries to expand their roles in the global biotech industry.
A disclaimer stated that all views expressed by guests were their own and did not represent those of their organizations.
